WEE1 and osteosarcoma: Another Wee1 inhibitor, MK-1775, enhanced the cytotoxic effect of gemcitabine in MG63, A673, U2OS, and HT-1080 osteosarcoma cell lines, OS-patient tumor explants, and a patient-derived mouse xenograft model.